Home > Category > Pharmaceutical > Target Product Profiles: Physician Insights on Key Attributes - Bipolar Disorder, A therapy that carries a lower risk of weight gain than quetiapine and has both antimanic and antidepressant effects for the treatment of bipolar disorder.
Market Research Report
Target Product Profiles: Physician Insights on Key Attributes - Bipolar Disorder, A therapy that carries a lower risk of weight gain than quetiapine and has both antimanic and antidepressant effects for the treatment of bipolar disorder.
|
|
PDF by E-Mail Approx. 1-2 business days
Hard Copy/CD-ROM Approx. 3-4 business days
If you need expedited delivery, please call us.
|
|
Table of Contents
- Introduction
- Using Target Product Profi les in Your Market Strategy
- Report Contents
- Target Product Profi le Methodology
- Etiology and Pathophysiology
- Overview
- Pathophysiology
- Neurochemical Dysfunction
- Intracellular Signaling Molecules
- Etiology
- Target Product Profi le Discussion-Bipolar Disorder
- Target Product Profi le Summary for Bipolar Disorder-2011
- Assessing Drug Development Opportunities
- Physician Survey Results
- Effi cacy
- Safety and Tolerability
- Delivery
- Estimated Patient Share
- Pricing Potential
- Forecast 2016 Pricing Environment
- Competitors to Watch
- Emerging Product Profi les
|
Related Report
|
|
Please inform me when related publications are released
|
|